(Q35119012)

6 August 2017

title

Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group (English)

1 reference

6 August 2017

1 reference

5

James R Anderson

1 reference

6 August 2017

6

Douglas S Hawkins

1 reference

6 August 2017

Suman Malempati

1

1 reference

6 August 2017

David A Rodeberg

2

1 reference

6 August 2017

Sarah S Donaldson

3

1 reference

6 August 2017

Elizabeth R Lyden

4

1 reference

6 August 2017

Carola A S Arndt

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

24 January 2011

1 reference

6 August 2017

1 reference

6 August 2017

volume

117

1 reference

6 August 2017

issue

15

1 reference

6 August 2017

page(s)

3493-3501

1 reference

Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from th

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140625

Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140625

Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140625

Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140625

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140625

The Intergroup Rhabdomyosarcoma Study-II.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140625

Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II).

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140625

The Intergroup Rhabdomyosarcoma Study-I. A final report

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140625

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140625

Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

9 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25887

Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25887

Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25887

Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140625

Nonparametric Estimation from Incomplete Observations

27 September 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25887

Late effects in children treated with radiation therapy for Wilms' tumor

21 January 2018

1 reference

12 December 2020

Rhabdomyosarcoma in infants younger than one year old

1 reference

12 December 2020

Infants younger than 1 year of age with rhabdomyosarcoma

1 reference

12 December 2020

1 reference

12 December 2020

The Third Intergroup Rhabdomyosarcoma Study

1 reference

12 December 2020

The challenging role of radiation therapy for very young children with rhabdomyosarcoma

1 reference

12 December 2020

It's not easy being small

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.25887

1 reference

6 August 2017

1 reference

6 August 2017

1 reference